Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07822880
What this trial is testing

Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India

Who this might be right for
Thyroid NeoplasmsCarcinoma, Non-Small-Cell Lung
Eli Lilly and Company 30
Not applicableStudy completedNCT02658513
What this trial is testing

Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer

Who this might be right for
Cancer of the ThyroidCancer of ThyroidThyroid Cancer+1 more
Royal Surrey County Hospital NHS Foundation Trust 35
Testing effectiveness (Phase 2)Study completedNCT00176748
What this trial is testing

Treatment for Patients With Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
University of Michigan Rogel Cancer Center 3
Not applicableEnrolling By InvitationNCT07755423
What this trial is testing

Stereotactic Body Radiotherapy for the Treatment of Distant Metastases in Thyroid Cancer: A Phase II Prospective Clinical Study

Who this might be right for
Thyroid Cancer Stage IV
Fudan University 44
Not applicableStudy completedNCT00693147
What this trial is testing

Late Postoperative Course of Patients With Mini Video Assisted Thyroidectomy (miVAT) Versus Classic Thyroidectomy (T)

Who this might be right for
Goiter
Aristotle University Of Thessaloniki 100
Not applicableLooking for participantsNCT01247597
What this trial is testing

DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

Who this might be right for
Pleuropulmonary BlastomaCystic NephromaOvarian Sertoli-Leydig Cell Tumors+2 more
National Cancer Institute (NCI) 1,500
Not applicableUnknownNCT00984191
What this trial is testing

Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

Who this might be right for
Papillary Thyroid Cancer
Chulalongkorn University 15
Testing effectiveness (Phase 2)Ended earlyNCT03463889
What this trial is testing

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

Who this might be right for
Thyroid Gland Carcinoma
University of California, San Francisco 12
Not applicableEnded earlyNCT04614389
What this trial is testing

Utility of Contrast-Enhanced Sonography and Shear Wave Elastography

Who this might be right for
Thyroid Nodule
University of Southern California 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05696548
What this trial is testing

Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)

Who this might be right for
Anaplastic Thyroid Cancer
National Cancer Center Hospital East 51
Testing effectiveness (Phase 2)Study completedNCT02702388
What this trial is testing

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Who this might be right for
Thyroid Cancer
Eisai Inc. 241
Large-scale testing (Phase 3)Study completedNCT01126060
What this trial is testing

Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain

Who this might be right for
Thyroid CarcinomaThyroidectomy
Samsung Medical Center 78
Testing effectiveness (Phase 2)Study completedNCT00896454
What this trial is testing

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Who this might be right for
Breast CancerHypercalcemia of MalignancyColon Cancer+13 more
Amgen 33
Not applicableNot Yet RecruitingNCT06820554
What this trial is testing

Thyroid Dysfunction Induced by Radiotherapy Treatment in Patients with Breast Cancer

Who this might be right for
Brest Cancer
Assiut University 97
Not applicableStudy completedNCT01624220
What this trial is testing

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Who this might be right for
Spinal Tumor
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Not applicableLooking for participantsNCT07287176
What this trial is testing

Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System

Who this might be right for
Thyroid NoduleThyroid GoiterAblation
Pulse Biosciences, Inc. 100
Not applicableStudy completedNCT05982821
What this trial is testing

Artificial Intelligence-assisted Contrast-enhanced Ultrasound Diagnosis of Thyroid Nodules

Who this might be right for
Thyroid Nodule
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1,955
Testing effectiveness (Phase 2)Ended earlyNCT03131206
What this trial is testing

Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer

Who this might be right for
ALK-positive Non-small Cell Lung Cancer (NSCLC)RET-positive Non-small Cell Lung Cancer (NSCLC)RET-positive Thyroid Cancer
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Next Page